Science Explorer Back to mapMap
Discussion
Company · Greifswald · Germany

Riemser Pharma (Germany)

riemser.comROR OpenAlex
Research works
28
▼ 8% vs 2018-21
Citations
494
17.6 per fractional work
Top-10% rate
24.7%
all institutions 10.0%
Open access
48%
world 40%
International
31%
world 18%
Riemser Pharma (Germany)

Not ranked overall: Riemser Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Riemser Pharma (Germany) work in?

In all years, 43% of research at Riemser Pharma (Germany) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (39%), Agricultural and Biological Sciences (23%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.1× the world's share of Life Sciences.

Life Sciences: 12 fractional works · 42.7% of its workAgricultural and Biological Sciences: 7 fractional works · 23.4% of its workAgronomy and Crop Science: 2 fractional works · 8.2% of its workEcology, Evolution, Behavior and Systematics: 2 fractional works · 7.8% of its workAnimal Science and Zoology: 1 fractional works · 4.4% of its workPlant Science: 1 fractional works · 2.4% of its workInsect Science: 0 fractional works · 0.6% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 9.5% of its workMolecular Biology: 1 fractional works · 5.0% of its workCancer Research: 0 fractional works · 1.4% of its workGenetics: 0 fractional works · 1.2% of its workBiochemistry: 0 fractional works · 1.2% of its workBiotechnology: 0 fractional works · 0.6% of its workImmunology and Microbiology: 2 fractional works · 6.6% of its workImmunology: 1 fractional works · 2.3% of its workParasitology: 0 fractional works · 1.8% of its workVirology: 0 fractional works · 1.6% of its workMicrobiology: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.0% of its workPharmacology: 1 fractional works · 2.4% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.3% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workHealth Sciences: 11 fractional works · 40.7% of its workMedicine: 11 fractional works · 38.6% of its workInfectious Diseases: 2 fractional works · 6.8% of its workEpidemiology: 2 fractional works · 6.5% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 5.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.5% of its workPhysiology: 1 fractional works · 3.5% of its workSurgery: 1 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.4% of its workOncology: 0 fractional works · 1.2% of its workNeurology: 0 fractional works · 1.2% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 1.2% of its workSmall Animals: 0 fractional works · 1.2% of its workDentistry: 0 fractional works · 0.6% of its workOral Surgery: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workPhysical Sciences: 3 fractional works · 11.5% of its workChemistry: 2 fractional works · 7.4% of its workSpectroscopy: 1 fractional works · 3.0% of its workOrganic Chemistry: 1 fractional works · 2.6% of its workAnalytical Chemistry: 0 fractional works · 1.8% of its workComputer Science: 1 fractional works · 2.0% of its workInformation Systems: 1 fractional works · 2.0% of its workEnvironmental Science: 0 fractional works · 1.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.5% of its workPollution: 0 fractional works · 0.3% of its workGlobal and Planetary Change: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.3% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workAtmospheric Science: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 5.1% of its workPsychology: 0 fractional works · 1.8% of its workSocial Psychology: 0 fractional works · 1.8% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.2% of its workDecision Sciences: 0 fractional works · 1.2% of its workManagement Science and Operations Research: 0 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workArts and Humanities: 0 fractional works · 0.4% of its workHistory and Philosophy of Science: 0 fractional works · 0.4% of its workALL ITS WORKRiemser Pharma(Germany)28fractional works, all years
Life Sciences43%Physical Sciences11%Health Sciences41%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Agricultural and Biological Sciences723.4%
    2. Biochemistry, Genetics and Molecular Biology39.5%
    3. Immunology and Microbiology26.6%
    4. Pharmacology, Toxicology and Pharmaceutics13.0%
    5. Neuroscience00.3%
    1. Medicine1138.6%
    2. Veterinary01.2%
    3. Dentistry00.6%
    4. Health Professions00.3%
    1. Chemistry27.4%
    2. Computer Science12.0%
    3. Environmental Science01.6%
    4. Engineering00.3%
    5. Earth and Planetary Sciences00.3%
    1. Psychology01.8%
    2. Business, Management and Accounting01.2%
    3. Decision Sciences01.2%
    4. Social Sciences00.6%
    5. Arts and Humanities00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.32× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.04× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.52× its world share, 0 worksImmunology and Micro…Computer Science: 2.38× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 1.58× its world share, 0 worksEarth and Planetary …Environmental Science: 0.74× its world share, 0 worksEnvironmental ScienceMedicine: 1.17× its world share, 1 worksMedicineArts and Humanities: 1.28× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 3.45× its world share, 0 worksBusiness, Management…Decision Sciences: 11.51× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 11.5×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Decision Sciences11.51×0 works
  2. Immunology and Microbiology5.52×0 works
  3. Business, Management and Accounting3.45×0 works
  4. Agricultural and Biological Sciences3.32×0 works
  5. Computer Science2.38×1 works
  6. Earth and Planetary Sciences1.58×0 works
  7. Arts and Humanities1.28×0 works
  8. Medicine1.17×1 works
  9. Biochemistry, Genetics and Molecular Biology1.04×0 works
  10. Environmental Science0.74×0 works

What are the most cited papers from Riemser Pharma (Germany)?

The most cited paper from Riemser Pharma (Germany) is "Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool" (Thomas Hoenen et al., 2015), with 241 citations. Next come "Comparison of Porcine Epidemic Diarrhea Viruses from Germany and the United States, 2014" (136) and "Development of an oral vaccine for immunisation of rainbow trout (Oncorhynchus mykiss) against viral haemorrhagic septicaemia" (118).

Most cited papers
#PaperReleasedCitations
1 Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool Thomas Hoenen et al. · Emerging infectious diseases Open access 18 Dec 2015 241
2 Comparison of Porcine Epidemic Diarrhea Viruses from Germany and the United States, 2014 Dennis Hanke, Maria Jenckel, A. A. Petrov et al. · Emerging infectious diseases Open access Dec 2014 136
3 Development of an oral vaccine for immunisation of rainbow trout (Oncorhynchus mykiss) against viral haemorrhagic septicaemia Malte Adelmann, Bernd Köllner, Sven Michael Bergmann et al. · Vaccine 19 Dec 2007 118
4 The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation Paul Kamudoni, Benjamin Mueller, Jason C. G. Halford et al. · Health and Quality of Life Outcomes Open access 8 Jun 2017 101
5 Oral immunisation against classical swine fever (CSF): onset and duration of immunity Volker Kaden, Bodo M. H. Lange · Veterinary Microbiology Oct 2001 78
All 78 most cited papers, with filters and sorting

Which keywords describe research at Riemser Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Genetic Characterization, Vaccine, Viral Pathogenesis, Immune Response, African Swine Fever and Foot-and-Mouth Disease.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Epidemiology8▲ 7.3×20 topics
  2. Pathogenesis5▲ 32×10 topics
  3. Genetic Characterization4▲ 252×2 topics
  4. Vaccine3▲ 30×6 topics
  5. Viral Pathogenesis3▲ 137×3 topics
  6. Immune Response2▲ 14×6 topics
  7. African Swine Fever2▲ 242×1 topic
  8. Foot-and-Mouth Disease2▲ 242×1 topic
  9. Climate Change2▲ 2.8×5 topics
  10. Vaccines2▲ 101×2 topics
  11. Bluetongue Virus2▲ 266×1 topic
  12. Culicoides Biting Midges2▲ 266×1 topic
  13. Infection2▲ 20×2 topics
  14. Quality of Life1▲ 3.8×3 topics
  15. Genetic Testing1▲ 26×2 topics
  16. Genomic Sequencing1▲ 28×2 topics
  17. Treatment1▲ 3.3×3 topics
  18. Epidemiological Study1▲ 48×2 topics
  19. Myocarditis1▲ 96×1 topic
  20. Norovirus1▲ 71×1 topic
  21. Rotavirus1▲ 71×1 topic
  22. Viral Infection1▲ 53×1 topic
  23. Coronavirus1▲ 30×2 topics
  24. Medical Ethics1▲ 20×1 topic
  25. Patient Rights1▲ 37×1 topic

Which research topics does Riemser Pharma (Germany) publish most on?

By volume in 2022-now: AI and HR Technologies, Innovations and Analysis in Business and Education, Vector-Borne Animal Diseases and Internet of Things and AI.

AI and HR Technologies0AI and HR Technologies: 0 fractional worksInnovations and Analysis…0Innovations and Analysis in Business and Education: 0 fractional worksVector-Borne Animal Dise…0Vector-Borne Animal Diseases: 0 fractional worksInternet of Things and AI0Internet of Things and AI: 0 fractional worksRabies epidemiology and control: 0 fractional worksViral Infections and Vectors: 0 fractional worksVirology and Viral Disea…0Virology and Viral Diseases: 0 fractional worksHuman-Animal Interaction…0Human-Animal Interaction Studies: 0 fractional worksAnimal Disease Managemen…0Animal Disease Management and Epidemiology: 0 fractional worksWeb and Library Services0Web and Library Services: 0 fractional works
Organizational Behavior and Human Resource ManagementManagement Science and Operations ResearchEcology, Evolution, Behavior and SystematicsInformation Systems5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 AI and HR Technologies Organizational Behavior and Human Resource Management 0 works
  2. 2 Innovations and Analysis in Business and Education Management Science and Operations Research 0 works
  3. 3 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 0 works
  4. 4 Internet of Things and AI Information Systems 0 works
  5. 5 Rabies epidemiology and control Virology 0 works
  6. 6 Viral Infections and Vectors Infectious Diseases 0 works
  7. 7 Virology and Viral Diseases Epidemiology 0 works
  8. 8 Human-Animal Interaction Studies Genetics 0 works
  9. 9 Animal Disease Management and Epidemiology Agronomy and Crop Science 0 works
  10. 10 Web and Library Services Information Systems 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.7%not open52.3%

World: 40% of research is openly available.

with international co-authors31.0%domestic only69.0%

World: 18% is written across borders.

How has Riemser Pharma (Germany)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Riemser Pharma (Germany) as a percentage of every work published that year, 0.000012% in 2024.

still counting0.00010%0.00020%0.00030%Riemser Pharma (Germany)0.000010% in 20251990200020102020

Fractional works of Riemser Pharma (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Greifswald

All research institutions in Greifswald

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Riemser Pharma (Germany). Posts are plain text and can be reported.